The Research on the Construction of PCV2 DNA Vaccine (Pcdna-Pcv-orf2-iss) and Combined Immunization with Molecular Adjuvants.

ZHANG Jian-yuan,WANG Hong-ning,CHEN Jin-rui,GAO Rong,HUANG Yong,LUO Hao,CHEN Jian-lin,ZHENG Min
2009-01-01
Abstract:Amplified the ORF2 gene coding CAP protein in the strains of PCV-whn by PCR method.Synthesized a CpG oligodeoxynuleotide(ODN),designed the primers and amplified it.Then inserted the results of the amplification in the pcDNA3.1(+),and constructed a novel DNA vaccine(pcDNA-PCV-ORF2-ISS)checked by sequencing.Piglets were immunized with the vaccine and five kind of cytokines(IL6/4,IL-2,IL-4,IL-6,IFN-γ).After that,the specific antibody were detected by the ELISA assay,and the number of CD3+,CD4+,CD8+ T lymphocytes were counted by Fluorescence Activated Cell Sorter(FACS).The results were as follows: The specific antibodies to the PCV2 mounted significantly in the sera from the pcDNAPCV-ORF2-ISS vaccinated piglets(P0.05).And the pcDNA-PCV-ORF2-ISS DNA vaccine could remarkably provoked the proliferation of CD3+,CD4+,CD8+T-lymphocytes of pig in vitro in comparison with the control(P0.05).The immune efficiency of the molecular adjuvants in order of immune enhancement were IL-6,CpG,IL-6/4,IL-2,IL-4 and IFN-γ,respectively,which demonstrated that IL-6 and CpG were the best.
What problem does this paper attempt to address?